Key facts
- It has raised $125.0M across 6 recorded rounds; the latest was Later Stage VC (Series D) ($125.0M) in Apr 2018.
- 6 institutional filers report fund marks on Twist Bioscience across 27 filings.
- Twist Bioscience has filed 11 Form Ds with the SEC since 2013, most recently Apr 2018 ($50.0M sold to 1 investors).
Free account
See the evidence behind this price
- ·Post-money valuations for all 6 rounds
- ·Watchlist + deal alerts for Twist Bioscience
Create free account
No card required
Funding rounds
6 roundsApr 2018Later Stage VC (Series D)$125.0M▮
About Twist Bioscience
- Industry
- Drug Discovery
PA Mark — not yet priced
Twist Bioscience doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Pro members can request priority coverage with a 48-hour turnaround.
Recorded secondary trades
No prints on record
No secondary trades in Twist Bioscience shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Pro members can request priority coverage with a 48-hour turnaround.
Institutional fund marks
6 filers · latest Jun 20266 SEC-registered funds reported 27 fair-value marks on Twist Bioscience between Apr 2025 and Jun 2026. Filer-level marks and implied $/share are available to Pro members.